Kay Abesamis currently works for Pfizer and has recently started a new role as Director of Global Marketing in prostate cancer for Talzenna in the Oncology business unit. She joined Pfizer in April 2014 as part of the Biosimilars Global Marketing and Commercial Development team, where she was responsible for developing commercialization strategies for Pfizer biosimilars. Most recently, she was the Global Marketing Lead for Bosulif, a treatment for Chronic Myeloid Leukemia and the anchor brand the Pfizer Hematology portfolio. She started her career in the pharmaceutical industry with Organon in the Netherlands, and successively worked for Schering Plough and Merck & Co. in the US prior to joining Pfizer. She has built a solid track record of achievement across a broad range of commercial roles, including global marketing, US in-line marketing, commercial development, alliance management, and business development, and has experience in Women’s Health, CNS, Inflammation and Hematology-Oncology indications. Kay has an MBA in Finance and Marketing from the University of Rochester, and a Master of Science degree in Molecular Biology & Biotechnology from the University of the Philippines.